Standard Diagnosis and Treatment of Severe Pneumonia

Note: This article is intended to provide educational information and does not replace a physician’s examination or treatment plan. Severe pneumonia can progress rapidly; patients with shortness of breath, cyanosis, altered mental status, hypotension, or low SpO₂ require emergency care immediately.

Diagnosis and treatment of severe pneumonia require simultaneous management: determining the severity of the illness, identifying potentially treatable pathogens, starting antibiotics at the appropriate time, and protecting respiratory function. Clinicians must also distinguish community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and aspiration pneumonia, because the risk of antimicrobial resistance and treatment strategies differ.

1. Recognizing severe pneumonia and initial assessment

Severe pneumonia is not identified solely by chest X-ray findings. Overall condition, breathing, circulation, mental status, and signs of organ failure must be assessed. Concerning findings include rapid breathing, increased work of breathing, hypoxemia, hypotension, oliguria, confusion, metabolic acidosis, or the need for ventilatory support.

ABCDE approach

A – Airway: assess the ability to protect the airway, the risk of aspiration, and the presence of airway secretions.
B – Breathing: measure SpO₂, obtain an arterial blood gas when needed, assess the response to oxygen, and look for signs of respiratory muscle fatigue.
C – Circulation: measure blood pressure and peripheral perfusion, check lactate when shock is suspected, establish intravenous access, and manage sepsis according to the facility’s protocol.
D – Disability: assess mental status and agitation or drowsiness caused by hypoxia, infection, or medications.
E – Exposure: look for other sources of infection, rash, dehydration, and underlying conditions that increase the risk of death.

Scores such as CURB-65 or PSI can support hospital-admission decisions in CAP but do not replace clinical assessment. When respiratory failure, shock, or multiorgan failure is present, intensive care treatment should be considered.

2. Testing and classification of CAP, HAP, and VAP

CAP: community-acquired pneumonia

CAP develops outside the hospital or early after admission. Diagnosis is generally based on symptoms of lower respiratory tract infection, systemic signs, and a new infiltrate on chest imaging. X-rays may be inconclusive early on; chest CT is used when clarification of the diagnosis or complications is needed, not as a routine test for every patient.

In severe CAP, blood cultures and respiratory specimens should be obtained before antibiotics if doing so will not delay treatment. Respiratory virus PCR testing may be useful depending on the season and epidemiology. Procalcitonin should not be used alone to decide against starting antibiotics when bacterial CAP is clinically suspected.

HAP and VAP

Hospital-acquired pneumonia (HAP) is generally defined as pneumonia that develops at least 48 hours after hospital admission and was neither present nor incubating at the time of admission. Ventilator-associated pneumonia (VAP) develops more than 48 hours after endotracheal intubation. Diagnosis is based on a new or worsening pulmonary infiltrate together with signs of infection such as fever, increased white blood cell count, purulent sputum, or worsening oxygenation; no single criterion is perfect.

A respiratory specimen should be collected for culture before the first antibiotic dose if feasible. The specimen may be sputum, an endotracheal aspirate, or material obtained by bronchoscopy, depending on the patient’s condition and local procedures. Results must be interpreted together with specimen quality, disease progression, and the hospital’s antimicrobial-resistance patterns.

3. Principles of treating severe pneumonia

Early antibiotics, but with a strategy

In septic shock or when the likelihood of infection is very high, intravenous antibiotics should be administered promptly after appropriate specimens are collected; treatment should not be delayed while awaiting culture results. Initial selection depends on the type and severity of pneumonia, prior antibiotic exposure, length of hospital stay, history of drug-resistant organisms, kidney function, and local antibiograms.

Severe CAP generally requires combination therapy covering pneumococcus and atypical bacteria; in some situations, coverage for methicillin-resistant Staphylococcus aureus or Gram-negative bacilli is also needed based on risk factors.
HAP/VAP carries a risk of drug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa. Empiric regimens should be based on the hospital antibiogram and individual risk factors; one formula should not be applied mechanically everywhere.
Avoid using antivirals, antifungals, or broad-spectrum antibiotics without appropriate clinical, microbiological, or epidemiological indications.

After 48–72 hours, response and culture results should be reviewed to de-escalate antibiotics when possible. Adjust doses according to kidney function, body weight, and dialysis; monitor for toxicity. Treatment duration depends on the pathogen, response, and complications. For HAP/VAP with a good response, many modern regimens generally favor shorter courses than older practice, but the final decision rests with the treating physician.

Respiratory and circulatory support

Conventional oxygen therapy, high-flow oxygen, noninvasive ventilation, or invasive ventilation is selected according to the severity of respiratory failure, mental status, and ability to protect the airway. When progressive acute respiratory distress syndrome is present, lung-protective ventilation with appropriate pressure and volume limits is fundamental. Patients with severe hypoxemia may require prone positioning when appropriate and monitoring in the ICU.

If shock is present, fluid resuscitation must be individualized, avoiding overload in patients with heart failure, kidney failure, or severe lung injury. If blood pressure remains low after fluid assessment, vasopressors are generally considered; the target and drug selection are determined by the critical-care team.

4. Aspiration pneumonia, prevention, and key points

Distinguishing aspiration pneumonitis from aspiration pneumonia

Aspiration of gastric contents can cause chemical pneumonitis, which often begins suddenly after aspiration and does not always require antibiotics. In contrast, aspiration pneumonia is an infection following aspiration of oropharyngeal secretions or gastric contents, and is generally suspected when fever, cough, purulent sputum, and progressive or nonresolving infiltrates are present.

Anaerobic coverage should not be added automatically for every case of aspiration pneumonia. Expanded anaerobic coverage is generally considered only when there is a lung abscess, empyema, or severe periodontal disease, based on the physician’s assessment.

Preventing complications and reassessment

Assess swallowing and eating position in people with impaired consciousness, stroke, or neurological disease.
Maintain oral hygiene, limit unnecessary sedation, and elevate the head of the bed when appropriate.
For patients on mechanical ventilation, follow the VAP prevention bundle: shorten the duration of ventilation, perform hand hygiene, provide airway care, and assess daily for the ability to wean.
Look for complications such as pleural effusion, abscess, sepsis, acute kidney injury, and malnutrition.

The core principle of treating severe pneumonia is not simply to change antibiotics. Clinicians must reassess the diagnosis, control the source of infection, optimize ventilation–perfusion, adjust fluids, and identify noninfectious conditions such as pulmonary edema, pulmonary embolism, or exacerbation of underlying lung disease. Patients and families should provide a medication list, allergy history, recent antibiotic use, duration of hospitalization, and aspiration risk to support safer treatment selection.

Diagnosing and Treating Severe Pneumonia: A Practical Guide